Doherty P C, Zinkernagel R M
Clin Exp Immunol. 1975 Feb;19(2):355-66.
Following intracerebral (i.c.) inoculation DBA/2 (H-2d) mastocytoma cells (P815) grow to concentrations of greater than 10,000/mul in cerebrospinal fluid (CSF) of H-2 compatible BALB/c mice, but are completely eliminated from 90% of such animals within 12 days. A similar pattern occurs in allogeneic C57BL (H-2b) and random-bred WEHI mice, whereas syngeneic DBA/2 mice die within 7 days from unrestricted tumour growth. Rejection in BALB/c mice is enhanced by prior exposure to the tumour, but is severely depressed by pretreatment with cyclophosphamide. Leucocytes responsible for eliminating the mastocytoma are apparently not active against sarcoma 180 cells injected simultaneously. Subsequent to intraperitoneal inoculation with mastocytoma cells both BALB/c and C57BL mice generate significant cytotoxic activity in spleen, as measured by an in vitro 51Cr release assay. Cytolysis is abrogated by prior incubation of spleen cells with AKR anti-O ascitic fluid and complement, but not by normal AKR ascitic fluid and complement. Following i.c. exposure, however, much lower levels of cytotoxic activity are found in spleen, though specifically sensitized lymphocytes are also present in lymph nodes of the cervical chain.
脑内接种后,DBA/2(H-2d)肥大细胞瘤细胞(P815)在H-2相容的BALB/c小鼠的脑脊液(CSF)中生长至浓度大于10,000/μl,但在12天内90%的此类动物体内的肿瘤细胞被完全清除。在同种异体C57BL(H-2b)和随机繁殖的WEHI小鼠中也出现类似模式,而同基因DBA/2小鼠则因肿瘤不受限制地生长在7天内死亡。预先接触肿瘤可增强BALB/c小鼠的排斥反应,但环磷酰胺预处理会严重抑制这种反应。负责清除肥大细胞瘤的白细胞显然对同时注射的肉瘤180细胞没有活性。腹腔接种肥大细胞瘤细胞后,通过体外51Cr释放试验测定,BALB/c和C57BL小鼠的脾脏均产生显著的细胞毒性活性。用AKR抗O腹水和补体预先孵育脾细胞可消除细胞溶解作用,但正常AKR腹水和补体则不能。然而,脑内暴露后,脾脏中的细胞毒性活性水平要低得多,尽管颈链淋巴结中也存在特异性致敏淋巴细胞。